Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas

American Journal of Dermatopathology

Volumn 30, Issue 6, 2008, Pages 549-554

  Yang, Hui Min ^a   Cabral, Erik ^b   Dadras, Soheil S ^b   Cassarino, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Basal cell carcinoma; D2 40; Podoplanin; Sebaceoma; Sebaceous adenoma; Sebaceous carcinoma; Squamous cell carcinoma

Indexed keywords

PODOPLANIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; TUMOR MARKER;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; ADENOMA; CASE CONTROL STUDY; CELL PROLIFERATION; COMPARATIVE STUDY; HYPERPLASIA; METABOLISM; PATHOLOGY; SEBACEOUS GLAND; SEBACEOUS GLAND TUMOR; SKIN TUMOR;

ADENOCARCINOMA, SEBACEOUS; ADENOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPLASIA; SEBACEOUS GLAND NEOPLASMS; SEBACEOUS GLANDS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 59849108120     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31816d6513     Document Type: Article

References (27)

1. Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111: 2151-2157.
2. Wolfe JT III, Yeatts RP, Wick MR, et al. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984;8:597-606.
3. Doxanas MT, Green WR. Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol. 1984;102:245-249.
4. Cabral ES, Auerbach A, Killian JK, et al. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry. Am J Dermatopathol. 2006;28:465-471.
5. Kanitakis J, al-Rifai I, Faure M, et al. Thomsen-Friedenreich and its precursor (Tn) antigen expression in normal skin and in benign cutaneous tumours: a marker for sebaceous differentiation. Acta Derm Venereol. 1998;78:173-176.
6. Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol. 1999;21:426-431.
7. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394.
8. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166: 913-921.
9. Dadras SS, Lange-Asschenfeldt B, Velasco P, et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol. 2005;18:1232-1242.
10. Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol. 2003;162:1951-1960.
11. Massi D, Puig S, Franchi A, et al. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol. 2006;59:166-173.
12. McKee PH, Calonje E, Granter SR. Pathology of the Skin. 3rd ed. Elsevier Mosby; Philadelphia 2005:20-21,475-476,1574-1583.
13. Troy JL, Ackerman AB. Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol. 1984;6:7-13.
14. Ansai S, Hashimoto H, Aoki T, et al. A histochemical and immunohistochemical study of extra-ocular sebaceous carcinoma. Histopathology. 1993;22:127-133.
15. Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52:317-325.
16. McBride SR, Leonard N, Reynolds NJ. Loss of p21(WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma. J Clin Pathol. 2002;55:763-766.
17. Niu Y, Zhou Z, Liu F, et al. Expression of P16 protein and Bcl-2 protein in malignant eyelid tumors. Chin Med J. 2002;115:21-25.
18. Nussen S, Ackerman AB. Sebaceous "adenoma" is sebaceous carcinoma. Dermatopathol Pract Concept. 1998;4:5-14.
19. Gomaa AH, Yaar M, Bhawan J. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol. 2007;29:18-21.
20. Sinard JH. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma. Arch Ophthalmol. 1999;117:776-783.
21. Martinka M, Trotter M, White V. Cytokeratin 7: aid to differential diagnosis of ocular sebaceous carcinomas, squamous cell and basal cell carcinomas. J Cutan Pathol. 2000;26:564. Abstract.
22. Schirren CG, Stefani FH, Sander CA, et al. Ocular sebaceous carcinoma and basal cell carcinoma show different profiles of cytokeratin intermediate filaments. J Cutan Pathol. 1997;24:123. Abstract.
23. Izikson L, Bhan A, Zembowicz A. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors. Am J Dermatopathol. 2005;27:91-95.
24. Nelson BR, Hamlet KR, Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol. 1995;33:1-15.
25. Rao NA, Hidayat AA, McLean IW, et al. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13:113-122.
26. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med.2001;7: 186-191.
27. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med.2001;7:192-198.